technewslit, Health authorities in Sweden authorized the start of a clinical trial testing insulin-producing cells from donors engineered to prevent immune reactions in people with type 1 diabetes.
https://sciencebusiness.technewslit.com/?p=45412
#News #Press #Science #Business #Type1Diabetes #Insulin #IsletCells #Pancreas #Biotechnology #StemCells #Autoimmune #Transplant #Allogeneic #Sweden
Add comment